Operating Lease, Right-of-Use Asset of GRI Bio, Inc. from 31 Dec 2022 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
GRI Bio, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2022 to 31 Dec 2025.
  • GRI Bio, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $71,000, a 41% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

GRI Bio, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $71,000 -$49,000 -41% 31 Dec 2025 10-K 30 Jan 2026 2025 FY
Q3 2025 $84,000 -$47,000 -36% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $97,000 -$44,000 -31% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $109,000 -$43,000 -28% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $120,000 +$106,000 +757% 31 Dec 2024 10-K 30 Jan 2026 2025 FY
Q3 2024 $131,000 +$103,000 +368% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $141,000 +$100,000 +244% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $152,000 31 Mar 2024 10-Q 10 May 2024 2024 Q1
Q4 2023 $14,000 -$53,000 -79% 31 Dec 2023 10-K 14 Mar 2025 2024 FY
Q3 2023 $28,000 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $41,000 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q4 2022 $67,000 31 Dec 2022 10-K 28 Mar 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.